Until recently there were relatively few analysers available to measure concentrations of anaesthetic gases and vapours accurately. The Beckman LB-2 infra-red medical gas analyser was capable of measuring halothane concentrations but it had a bulky, delicate sensor which had to be placed near the patient's head. The Engstrom Emma, a multigas analyser operating on the oscillating quartz crystal principle, was available but was sensitive to water vapour and hence had to be used only with dry or dried gases. 1 Devices such as the Drager Narcotest and Riken meter were also available and were usually used only to measure halothane. Both had an accuracy of 0.2% for a full scale reading of 7% and 3% respectively. The Riken meter required intermittent sampling and careful calibration. 2 Mass spectrometers have been available for quite some time but have not come into widespread medical use in Australia. Due to their high cost it is Anaesthesia and Intensive Care. Vo!. 16. No. 1. Februar!'. /988 not practical to have a separate mass spectrometer for each location requiring monitoring. Therefore mass spectrometer systems with multiplexed networks of sampling lines have been developed. These sample from each theatre in turn, and the results are displayed at each sampling site. Over 200 large operating theatre complexes in North America have been equipped with such mass spectrometer facilities.
Mass spectrometers have the advantage of being able to provide breath-by-breath read-outs of oxygen, carbon dioxide, nitrogen and volatile anaesthetic concentrations. Disadvantages are that the capital and running costs are extremely high. A problem also exists with shared sampling when override options are exercised in emergencies and other users are deprived. The intricacies and complexities of separating carbon dioxide and nitrous oxide peaks (both with mass/charge ratio of approximately 44) make the technique heavily dependent on technical backup.
Recent advances in electronic circuitry for infra-red spectrophotometry (more stable and miniaturised amplifiers) have led to the introduction of volatile anaesthetic monitors mounted on the anaesthetic machine. These measure absorbance which is proportional to partial pressure, but absorbance is not specific as is mass spectrometry. They may be used either for regular calibration of vaporisers on anaesthetic machines or for the continuous measurement of respired anaesthetic agent concentrations, provided the agent is specified.
Vaporiser calibration
When the monitors are used to calibrate vaporisers, the monitors themselves should be checked before, during and after the procedure by being exposed to known concentrations of vapour. Response times and effects of water vapour and other agents are not important in this context. Nevertheless monitors should be stable and accurate to ± 0.1 % of vapour concentration.
Some vaporisers tend to under-deliver progressively with use by as much as 30%; occasional errors of up to 70% have been encountered. The true concentration delivered at each flow during calibration should be recorded with the test date on a card attached to each vaporiser. A check calibration should be carried out at least annually. If the manufacturer's specifications are not met, the vaporiser should be serviced.
Patient circuit monitoring
Most anaesthetists rely on vaporisers being reasonably accurate, but with circle systems the fresh gas mixture may differ greatly from the inspired gas mixture. It is obviously an advantage to know vapour concentrations in inspired, or even better, expired gas, particularly in patients who are paralysed and ventilated. If a desired concentration of volatile agent is reliably and continuously maintained, the incidence of awareness should be reduced.
Volatile anaesthetic agent monitors for in-line use should be accurate and reliable under working conditions, and should have a response time adequate for breath-by-breath analysis, i.e. better than 1.0 second for 90% of the signal. They can be used to measure halothane, enflurane, isoflurane and methoxyflurane. Their major disadvantage is that each uses the same infra-red wavelength band (3.3-3.5 J.1m for the Datex Normac) for all agents monitored, and they therefore cannot distinguish between agents. Errors will occur when more than one volatile agent is used or the button for the wrong agent is selected. The Datex Normac is calibrated by selecting the enflurane channel and using a manufacturer supplied aerosol can of a Freon gas to obtain the correct readout according to the value on the can. All channels are then assumed to be calibrated. Our recent study I showed that this monitor was accurate, linear, and stable in the presence of nitrous oxide and water vapour and could adequately track concentrations at respiratory rates of up to 25 breaths/minute. The presence of alcohol in the breath causes the monitor to read high.
Other monitors for measuring volatile anaesthetic agents have now become available. Some of these multi-agent monitors have the facility to measure nitrous oxide concentrations using another specific infra-red wavelength. All-inone anaesthesia gas monitors are now available to measure instantaneous and end-tidal carbon dioxide, inspiratory and expiratory oxygen, and nitrous oxide as well as inspiratory-expiratory concentrations of either halothane, enflurane or isoflurane.
In summary, a breath-by-breath analysis of anaesthetic agent concentration is very useful for teaching the pharmacokinetics of these agents and for teaching the interrelationship between ventilation, fresh gas flow, and breathing circuit capacity. Patient safety is enhanced with gas monitoring when using low fresh gas flow rates, and the reliable maintenance of adequate concentrations of anaesthetic agents at all times may reduce the incidence of awareness.
Monitoring environmental levels
It is now well accepted that there should be effective control of waste or dumped anaesthetic gas. To achieve this there should be a five-point approach of active scavenging, good fresh air conditioning, gas-tight circuits and good machine maintenance, attention to aspects of clinical practice, and periodic monitoring of ambient levels. 3 It is important to realise that the recommended maximum levels of volatile anaesthetics are well below the perceptible concentrations. It has been reported that the odour threshold for most halogenated anaesthetic agent vapours is about 50 ppm or 25 to 100 times the recommended exposure limit. 4 We tested this in a study of 22 people, made up of equal numbers of anaesthetists and laboratory staff who worked with anaesthetic agents. The concentration at which at least 90% of the group could smell the agents varied greatly among agents, being 10 ppm for methoxyflurane, 60 ppm for halothane, 200 ppm for enflurane and above 250 ppm for isoflurane. These data imply that some agents, especially enflurane and isoflurane, can only be detected at levels far in AnaesiJlesia and lntensire Care, J'ol. 16. No. 1. Februar.l '. 1988 excess of 50 ppm. In fact, less than 50% of the group could detect enflurane at 50 ppm and only about 20% of the group could detect isoflurane at 50 ppm. In contrast, 95% could smell 20 ppm methoxyflurane and about 90% could detect 50 ppm halothane. Thus, when halothane, enflurane or isoflurane can be smelt, at least 100 times the recommended environmental level (0.5 ppm) is likely to be present.
Two ways of monitoring exposure to waste anaesthetic agents are by use of a personal sampler with subsequent analysis and continuous monitoring of the work place. Personal samplers give the personal exposure for each worker while continuous monitoring gives the exposure levels at one particular place. Continuous monitoring is useful to detect 'hot-spots' caused by leaks in a pipeline supply, a faulty anaesthetic machine or inattention to pollution control during the administration of anaesthesia or the filling of vaporisers.
Analytically, the personal sampler method has the advantage of being able to both quantitatively and qualitatively analyse the sample taken over a working day. The method works by actively or passively adsorbing pollutants onto an appropriate medium in the sampler. During active sampling a battery-operated pump draws the air sample through the medium. In the passive sampler, diffusion rates of pollutants onto the sample medium are pre-determined so that the ambient pollutant concentration can be calculated. Before analysis the pollutants are desorbed from the sample medium either thermally or by use of an appropriate solvent. Gas chromatography is the preferred method of analysis. It should be noted that separate sampling media have to be used for nitrous oxide and the halogenated agents. However, more than one halogenated agent can be measured from one sampler.
Continuous monitoring of work stations is usually performed using infra-red gas analysers. 5 Anaesthesia and Intensive Care, Vol. 16, No. 1. February, 1988 The sample is drawn through the sampling cell of the analyser, which has been set and calibrated at a particular wavelength. It is therefore necessary to know what agent is present, and when multiple agents are present one analyser per agent is required. If environmental control is the aim, often only nitrous oxide is monitored as a marker of the amount of pollution. If many sites must be monitored, this can be achieved using an appropriate switching system between multiple sampling lines leading to the central analyser.
The National Health and Medical Research Council of Australia has laid down guidelines for the environmental levels of anaesthetic agents which can be achieved using the measures outlined above. 6 A program of monitoring recommended by ECRI consists of an annual comprehensive survey with less detailed quarterly follow-ups. 4 A repeat comprehensive survey is carried out if any problems are identified or if there are any changes to ventilation systems, anaestfiesia equipment or scavenging systems.
